NeuroLux has launched the first commercially manufactured Optofluidics device, providing drug delivery and optogenetics modalities. It is an implantable, lightweight, battery-free device with parameter control on the individual device level. The device combines soft microfluidic and microscale inorganic light-emitting diode probes for programmable pharmacology and optogenetics, designed to offer the features...
